Carregant...
Advanced Melanoma: Resistance Mechanisms to Current Therapies
Despite the recent advances in melanoma treatment, resistance to currently available immune and targeted therapies remains the major barriers to long-term disease control in many patients. Most often, this is associated with intrinsic/innate resistance to immune checkpoint inhibitors and acquired re...
Guardat en:
| Publicat a: | Hematol Oncol Clin North Am |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7991196/ https://ncbi.nlm.nih.gov/pubmed/33759769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2020.09.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|